To study the role of GLP-1R in microglial inflammation, BV-2 cells were preincubated with the selective GLP-1R agonist liraglutide (100 nM, Selleck, TX, USA) and the antagonist exendin(939) (200 nM, MCE, USA) for 24 h, followed by LPS (1 g/ml, SigmaAldrich, MO, USA) stimulation for 24 h
At Klinic, we specialize in semaglutide weight loss treatments and our team takes care of insurance verification and the entire prior authorization process so you can focus solely on your health objectives
Our clinicians assess your medical history and help you decide whether out treatment can help you on your weight loss journey
Wegovy BMI requirements generally include: A Body Mass Index (BMI) of 30 or higher , or A BMI of 27 or higher with weight-related health conditions BMI helps medical providers determine whether Wegovy for obesity Chicago treatment is appropriate